Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02829190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries

Study acronym: IRM-de-FLUX
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary and study completion dates: Dec 2023 to Dec 2027v6
  2. Notable Primary and study completion dates: Jan 2022 to Dec 2023v5
  3. Minor Re-verified, no change to tracked fieldsv4
  4. Notable Primary and study completion dates: Jan 2020 to Jan 2022v3
  5. Notable Primary and study completion dates: Aug 2018 to Jan 2020
    • Start date: Feb 2014 to Jan 6, 2014
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The phase-contrast MRI offers the advantage to combine precisely vascular flow measurements data with morphological images. Even if the anatomy of the external carotid artery is well known, data obtained through Phase contrast MRI could permit to progress in several fields of cranio-maxillofacial surgery as for example arteriovenous malformations,radionecrosis, head and neck micro-reconstructive surgery. The aim of this study is to establish and develop Phase-contrast MRI sequences for vascular flow characterization branches of the external carotid artery in healthy patients and in pathological cases.
Trial Details
NCT Number NCT02829190
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Conditions
(from sponsor)
Carotid Artery, External
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov